Drug intelligence / Profile preview

umbilical cord-derived mesenchymal stem cells (Peking University People's Hospital)

Development stage: Unknown
Lead developer: Peking University People's Hospital
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraarticular

Overview

An investigational cell therapy consisting of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) being developed by the Arthritis Clinic & Research Center at Peking University People's Hospital. The therapy involves isolating MSCs from the Wharton's jelly of human umbilical cords and administering them via intra-articular injection into the knee joint. It is designed to treat knee osteoarthritis by leveraging the cells' ability to differentiate into chondrocytes for cartilage regeneration and their secretion of anti-inflammatory factors to modulate the joint environment and reduce pain.

Other names: hUC-MSCsUC-MSCshuman umbilical cord-derived mesenchymal stem cellsmesenchymal stem cells from umbilical cord

Beyond the preview

Go deeper on umbilical cord-derived mesenchymal stem cells (Peking University People's Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (Peking University People's Hospital).

Explore the full profile